EN ISO 14971:2019/A11:2021
(Amendment)Medical devices - Application of risk management to medical devices (ISO 14971:2019)
Medical devices - Application of risk management to medical devices (ISO 14971:2019)
This document specifies terminology, principles and a process for risk management of medical devices, including software as a medical device and in vitro diagnostic medical devices. The process described in this document intends to assist manufacturers of medical devices to identify the hazards associated with the medical device, to estimate and evaluate the associated risks, to control these risks, and to monitor the effectiveness of the controls.
The requirements of this document are applicable to all phases of the life cycle of a medical device. The process described in this document applies to risks associated with a medical device, such as risks related to biocompatibility, data and systems security, electricity, moving parts, radiation, and usability.
The process described in this document can also be applied to products that are not necessarily medical devices in some jurisdictions and can also be used by others involved in the medical device life cycle.
This document does not apply to:
— decisions on the use of a medical device in the context of any particular clinical procedure; or
— business risk management.
This document requires manufacturers to establish objective criteria for risk acceptability but does not specify acceptable risk levels.
Risk management can be an integral part of a quality management system. However, this document does not require the manufacturer to have a quality management system in place.
NOTE Guidance on the application of this document can be found in ISO/TR 24971[9].
Medizinprodukte - Anwendung des Risikomanagements auf Medizinprodukte (ISO 14971:2019)
Dispositifs médicaux - Application de la gestion des risques aux dispositifs médicaux (ISO 14971:2019)
Le présent document spécifie la terminologie, les principes et un processus de gestion des risques relatifs aux dispositifs médicaux, y compris les logiciels utilisés en tant que dispositifs médicaux et les dispositifs médicaux de diagnostic in vitro. Le processus décrit dans le présent document vise à aider les fabricants de dispositifs médicaux à identifier les dangers associés au dispositif médical, à estimer et évaluer les risques correspondants, à maîtriser ces risques et à surveiller l'efficacité des moyens de maîtrise.
Les exigences du présent document s'appliquent à tous les stades du cycle de vie d'un dispositif médical. Le processus décrit dans le présent document s'applique aux risques associés à un dispositif médical, tels que les risques concernant la biocompatibilité, la sécurité des données et des systèmes, l'électricité, les parties en mouvement, le rayonnement et l'aptitude à l'utilisation.
Le processus décrit dans le présent document peut aussi s'appliquer aux produits qui ne sont pas nécessairement des dispositifs médicaux dans certaines juridictions et peut être utilisé par d'autres personnes impliquées dans le cycle de vie de dispositifs médicaux.
Le présent document ne s'applique pas à ce qui suit:
— les décisions relatives à l'utilisation d'un dispositif médical au cours d'une procédure clinique particulière; ou
— la gestion des risques commerciaux.
Le présent document impose aux fabricants d'établir des critères objectifs d'acceptabilité des risques, mais ne spécifie pas de niveaux de risque acceptables.
La gestion des risques peut faire partie intégrante d'un système de management de la qualité. Cependant, le présent document n'exige pas du fabricant qu'il mette en place un système de management de la qualité.
NOTE Des recommandations relatives à l'application du présent document sont données dans l'ISO/TR 24971[9].
Medicinski pripomočki - Uporaba obvladovanja tveganja pri medicinskih pripomočkih (ISO 14971:2019) - Dopolnilo A11
Ta dokument določa terminologijo, načela in postopek za obvladovanje tveganja medicinskih pripomočkov, vključno s programsko opremo kot medicinskim pripomočkom ter in vitro diagnostičnimi medicinskimi pripomočki. Postopek, opisan v tem dokumentu, je namenjen podpori proizvajalcem medicinskih pripomočkov pri prepoznavanju nevarnosti, povezanih z medicinskim pripomočkom, ocenjevanju in ovrednotenju povezanih tveganj, nadzorovanju teh tveganj ter spremljanju uspešnosti ukrepov nadzora.
Zahteve tega dokumenta se uporabljajo za vse faze življenjskega cikla medicinskega pripomočka. Postopek, opisan v tem dokumentu, se uporablja za tveganja, povezana z medicinskimi pripomočki, kot so tveganja v zvezi z biološko združljivostjo, varnostjo podatkov in sistemov, elektriko, premikajočimi se deli, sevanjem ter uporabljivostjo.
Postopek, opisan v tem dokumentu, je mogoče uporabiti tudi za izdelke, ki niso nujno medicinski pripomočki v nekaterih zakonodajah in ki jih morda uporabljajo tudi drugi, vključeni v življenjski cikel medicinskega pripomočka.
Ta dokument se ne uporablja za:
– odločitve glede uporabe medicinskega pripomočka v okviru določenega kliničnega postopka; ali
– obvladovanje poslovnega tveganja.
Ta dokument od proizvajalcev zahteva, da vzpostavijo objektivne kriterije za sprejemljivost tveganja, vendar ne določa stopenj sprejemljivega tveganja.
Obvladovanje tveganja je lahko sestavni del sistema vodenja kakovosti. Vendar pa ta dokument od proizvajalca ne zahteva, da ima uveden sistem vodenja kakovosti.
OPOMBA: Navodila za uporabo tega dokumenta so na voljo v standardu ISO/TR 24971[9].
General Information
Relations
Standards Content (Sample)
SLOVENSKI STANDARD
01-februar-2022
Medicinski pripomočki - Uporaba obvladovanja tveganja pri medicinskih
pripomočkih (ISO 14971:2019) - Dopolnilo A11
Medical devices - Application of risk management to medical devices (ISO 14971:2019)
Medizinprodukte - Anwendung des Risikomanagements auf Medizinprodukte (ISO
14971:2019)
Dispositifs médicaux - Application de la gestion des risques aux dispositifs médicaux
(ISO 14971:2019)
Ta slovenski standard je istoveten z: EN ISO 14971:2019/A11:2021
ICS:
11.040.01 Medicinska oprema na Medical equipment in general
splošno
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.
EUROPEAN STANDARD EN ISO 14971:2019/A11
NORME EUROPÉENNE
EUROPÄISCHE NORM
December 2021
ICS 11.040.01
English version
Medical devices - Application of risk management to
medical devices (ISO 14971:2019)
Dispositifs médicaux - Application de la gestion des Medizinprodukte - Anwendung des
risques aux dispositifs médicaux (ISO 14971:2019) Risikomanagements auf Medizinprodukte (ISO
14971:2019)
This amendment A11 modifies the European Standard EN ISO 14971:2019; it was approved by CEN on 27 October 2021.
CEN and CENELEC members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for
inclusion of this amendment into the relevant national standard without any alteration. Up-to-date lists and bibliographical
references concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to
any CEN and CENELEC member.
This amendment exists in three official versions (English, French, German). A version in any other language made by translation
under the responsibility of a CEN and CENELEC member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.
CEN and CENELEC members are the national standards bodies and national electrotechnical committees of Austria, Belgium,
Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of North Macedonia, Romania, Serbia,
Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom.
CEN-CENELEC Management Centre:
Rue de la Science 23, B-1040 Brussels
© 2021 CEN/CENELEC All rights of exploitation in any form and by any means
Ref. No. EN ISO 14971:2019/A11:2021 E
reserved worldwide for CEN national Members and for
CENELEC Members.
Contents Page
European foreword . 3
Annex ZA (informative) Relationship between this European standard and the
General Safety and Performance Requirements of Regulation (EU) 2017/745
aimed to be covered . 4
Annex ZB (informative) Relationship between this European standard and the
General Safety and Performance Requirements of Regulation (EU) 2017/746
aimed to be covered . 7
European foreword
This document (EN ISO 14971:2019/A11:2021) has been prepared by Technical Committee
CEN/CLC/TC 3 “Quality management and corresponding general aspects for medical devices” the
secretariat of which is held by NEN.
This Amendment to the European Standard EN ISO 14971:2019 shall be given the status of a national
standard, either by publication of an identical text or by endorsement, at the latest by June 2022, and
conflicting national standards shall be withdrawn at the latest by June 2022.
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. CEN [and/or CENELEC] shall not be held responsible for identifying any or all such patent
rights.
This Amendment to the European Standard EN ISO 14971:2019 has been prepared under a mandate
given to CEN by the European Commission and the European Free Trade Association, and supports
requirements of EU Regulation(s).
For relationship with EU Regulation(s), see informative Annex ZA, and ZB, which are an integral part of
this document.
Any feedback and questions on this document should be directed to the users’ national standards
body/national committee. A complete listing of these bodies can be found on the CEN websites.
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of North
Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the United
Kingdom.
Annex ZA
(informative)
Relationship between this European standard and the General Safety and
Performance Requirements of Regulation (EU) 2017/745 aimed to be
covered
This European standard has been prepared under a Commission’s standardisation request M/575 to
provide one voluntary means of conforming to the General Safety and Performance Requirements of
Regulation (EU) 2017/745 of 5 April 2017 concerning medical devices [OJ L 117].
Once this standard is cited in the Official Journal of the European Union under that Regulation, compliance
with the normative clauses of this standard given in Table ZA.1 confers, within the limits of the scope of
this standard, a presumption of conformity with the corresponding General Safety and Performance
Requirements of that Regulation, and associated EFTA regulations.
For application of this European standard under Regulation (EU) 2017/745,
1. the scope is limited to medical devices and accessories for a medical device as defined in that
Regulation and to products regulated as a device under that Regulation;
2. in case of differences between terms defined in this European standard and terms defined in that
Regulation, the terms defined in the Regulation shall prevail;
3. the manufacturer’s policy for establishing criteria for risk acceptability (see 4.2 of this European
standard) shall ensure that the criteria comply with the General Safety and Performance
Requirements of that Regulation.
Explanation on the correspondence of the standard and the General Safety and Performance
Requirements is included in Table ZA.1.
NOTE 1 Where a reference from a clause of this standard to the risk management process is made, the
risk management process needs to be in compliance with Regulation (EU) 2017/745. This means that
risks have to be ‘reduced as far as possible’, ‘reduced to the lowest possible level’, ‘reduced as far as
possible and appropriate’, ‘removed or reduced as far as possible’, ‘eliminated or reduced as far as
possible’, ’removed or minimized as far as possible’, or ‘minimized’, according to the wording of the
corresponding General Safety and Performance Requirement.
NOTE 2 The manufacturer’s policy for determining acceptable risk must be in compliance with General
Safety and Performance Requirements 1, 2, 3, 4, 5, 8, 9, 10, 11, 14, 16, 17, 18, 19, 20, 21 and 22 of the
Regulation.
NOTE 3 This Annex ZA is based on normative references according to the table of references in the
European Foreword, replacing the references in the core text.
NOTE 4 When a General Safety and Performance Requirement does not appear in Table ZA.1, it means
that it is not addressed by this European Standard.
EN ISO 14971:20
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.